LXEO
USDLexeo Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$8.300
High
$8.355
Low
$7.660
Volume
2.85M
Company Fundamentals
Market Cap
597.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.04M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $13
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Lexeo Therapeutics with a Buy and lowers the price target from $15 to $13.
Chardan Capital Maintains Buy on Lexeo Therapeutics, Raises Price Target to $17
Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics with a Buy and raises the price target from $15 to $17.
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.